Search

Your search keyword '"Taigen, Tyler"' showing total 189 results
Start Over Author "Taigen, Tyler"
189 results on '"Taigen, Tyler"'

2. Catheter ablation of atrial fibrillation in elderly and very elderly patients: safety, outcomes, and quality of life

Author

Tabaja, Chadi, Younis, Arwa, Santangeli, Pasquale, Madden, Ruth, Taigen, Tyler, Farwati, Medhat, Hayashi, Katsuhide, Braghieri, Lorenzo, Rickard, John, Klein, Benjamin M., Paul, Aritra, Dresing, Thomas J., Martin, David O., Bhargava, Mandeep, Kanj, Mohamed, Sroubek, Jakub, Nakagawa, Hiroshi, Saliba, Walid I., Wazni, Oussama M., and Hussein, Ayman A.

Published
2024
Full Text
View/download PDF

3. Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes

Author

Younis, Arwa, Tabaja, Chadi, Santangeli, Pasquale, Nakagawa, Hiroshi, Sipko, Joseph, Madden, Ruth, Bouscher, Patricia, Taigen, Tyler, Higuchi, Koji, Hayashi, Katsuhide, El Hajjar, Abdel Hadi, Chamseddine, Fatimah, Callahan, Thomas, Martin, David O., Nakhla, Shady, Kanj, Mohamed, Sroubek, Jakub, Lee, Justin Z., Saliba, Walid I., Wazni, Oussama M., and Hussein, Ayman A.

Published
2024
Full Text
View/download PDF

6. Efficacy of Drug-Coated Balloon Angioplasty in Pulmonary Vein Stenosis or Total Occlusion

Author

Denby, Kara J., Tereshchenko, Larisa G., Kanj, Mohamed, Taigen, Tyler, Callahan, Thomas, Dresing, Thomas, Tanaka Esposito, Christina, Santangeli, Pasquale, Hussein, Ayman, Hargrave, Jennifer, Wakefield, Brett, Skubas, Nikolaos J., Tovar Camargo, Oscar, Krishnaswamy, Amar, Nanjundappa, Aravinda, Puri, Rishi, Khatri, Jaikirshan, Kapadia, Samir, Suntharos, Patcharapong, Prieto, Lourdes, and Ghobrial, Joanna

Published
2024
Full Text
View/download PDF

8. Vascular access complications after catheter ablation of ventricular arrhythmias: Impact of vascular closure devices

Author

Tabaja, Chadi, Hight, Nolan, Younis, Arwa, Jadam, Shada, Demian, Joe, Hussein, Ayman, Sroubek, Jakub, Saliba, Walid, Kanj, Mohamed, Bhargava, Mandeep, Baranowski, Bryan, Callahan, Thomas, Chung, Mina, Dresing, Thomas, Lee, Justin, Higuchi, Koji, Liuba, Ioan, Martin, David, Nakhla, Shady, Rickard, John, Varma, Niraj, Taigen, Tyler, Wazni, Oussama, and Santangeli, Pasquale

Published
2024
Full Text
View/download PDF

11. Same-day discharge after atrial fibrillation ablation

Author

Aguilera, Jose, Hutt, Erika, Madden, Ruth, Kanj, Mohamed, Saliba, Walid, Rickard, John, Sroubek, Jakub, Callahan, Thomas, Chung, Mina, Baranowski, Brian, Martin, David, Dresing, Thomas, Wazni, Oussama M., Hussein, Ayman, Cantillon, Daniel, Patel, Divyang, Nakhla, Shady, and Taigen, Tyler

Published
2023
Full Text
View/download PDF

12. Ischemic or Coronary Evaluations in Patients With Monomorphic VT Electrical Storm Undergoing VT Ablation

Author

Alkhalaileh, Feras, Wazni, Oussama M., Kiang, Alan, Parker, Joshua, Ellis, Stephen, Kanj, Mohamed, Farwati, Medhat, Menon, Venugopal, Callahan, Thomas, Baranowski, Bryan, Nakhla, Shady, Taigen, Tyler, Santangeli, Pasquale, Kewan, Tariq, Cantillon, Daniel, Sroubek, Jakub, Rickard, John, Zmaili, Mohammad, Bhargava, Mandeep, Saliba, Walid I., Nakagawa, Hiroshi, and Hussein, Ayman A.

Published
2023
Full Text
View/download PDF

19. Acute post-procedural inducibility is a poor predictor of clinical outcomes in high-risk patients (PAINESD > 17) undergoing scar-related ventricular tachycardia ablation.

Author

Sipko, Joseph, Baranowski, Bryan, Bhargava, Mandeep, Callahan, Thomas D, Dresing, Thomas J, Higuchi, Koji, Hussein, Ayman A, Kanj, Mohamed, Lee, Justin, Martin, David O, Nakhla, Shady, Rickard, John J, Saliba, Walid I, Taigen, Tyler, Wazni, Oussama M, Santangeli, Pasquale, and Sroubek, Jakub

Abstract

Aims Ventricular tachycardia (VT) non-inducibility in response to programmed ventricular stimulation (PVS) is a widely used procedural endpoint for VT ablation despite inconclusive evidence with respect to clinical outcomes in high-risk patients. The aim is to determine the utility of acute post-ablation VT inducibility as a predictor of VT recurrence, mortality, or mortality equivalent in high-risk patients. Methods and results We conducted a retrospective analysis of high-risk patients (defined as PAINESD > 17) who underwent scar-related VT ablation at our institution between July 2010 and July 2022. Patients' response to PVS (post-procedure) was categorized into three groups: Group A, no clinical VT or VT with cycle length > 240 ms inducible; Group B, only non-clinical VT with cycle length > 240 ms induced; and Group C, all other outcomes (including cases where no PVS was performed). The combined primary endpoint included death, durable left ventricular assist device placement, and cardiac transplant (Cox analysis). Ventricular tachycardia recurrence was considered a secondary endpoint (competing risk analysis). Of the 1677 VT ablation cases, 123 cases met the inclusion criteria for analysis. During a 19-month median follow-up time (interquartile range 4–43 months), 82 (66.7%) patients experienced the composite primary endpoint. There was no difference between Groups A and C with respect to the primary [hazard ratio (HR) = 1.21 (0.94–1.57), P = 0.145] or secondary [HR = 1.18 (0.91–1.54), P = 0.210] outcomes. These findings persisted after multivariate adjustments. The size of Group B (n = 13) did not permit meaningful statistical analysis. Conclusion The results of post-ablation PVS do not significantly correlate with long-term outcomes in high-risk (PAINESD > 17) VT ablation patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

22. Catheter ablation of atrial fibrillation in elderly and very elderly patients: safety, outcomes, and quality of life

Author

Tabaja, Chadi, primary, Younis, Arwa, additional, Santangeli, Pasquale, additional, Madden, Ruth, additional, Taigen, Tyler, additional, Farwati, Medhat, additional, Hayashi, Katsuhide, additional, Braghieri, Lorenzo, additional, Rickard, John, additional, Klein, Benjamin M., additional, Paul, Aritra, additional, Dresing, Thomas J., additional, Martin, David O., additional, Bhargava, Mandeep, additional, Kanj, Mohamed, additional, Sroubek, Jakub, additional, Nakagawa, Hiroshi, additional, Saliba, Walid I., additional, Wazni, Oussama M., additional, and Hussein, Ayman A., additional

Published
2023
Full Text
View/download PDF

23. Catheter-Based Electroporation

Author

Tabaja, Chadi, primary, Younis, Arwa, additional, Hussein, Ayman A., additional, Taigen, Tyler L., additional, Nakagawa, Hiroshi, additional, Saliba, Walid I., additional, Sroubek, Jakub, additional, Santangeli, Pasquale, additional, and Wazni, Oussama M., additional

Published
2023
Full Text
View/download PDF

25. Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation: Results of CONVERGE Clinical Trial

Author

DeLurgio, David B., Crossen, Karl J., Gill, Jaswinder, Blauth, Christopher, Oza, Saumil R., Magnano, Anthony R., Mostovych, Mark A., Halkos, Michael E., Tschopp, David R., Kerendi, Faraz, Taigen, Tyler L., Shults, Christian C., Shah, Manish H., Rajendra, Anil B., Osorio, Jose, Silver, Jonathan S., Hook, Bruce G., Gilligan, David M., and Calkins, Hugh

Published
2020
Full Text
View/download PDF

26. Effects of Contact Force on Lesion Size During Pulsed Field Catheter Ablation: Histochemical Characterization of Ventricular Lesion Boundaries.

Author

Hiroshi Nakagawa, Castellvi, Quim, Neal, Robert, Girouard, Steven, Laughner, Jacob, Atsushi Ikeda, Masafumi Sugawara, Yoshimori An, Hussein, Ayman A., Nakhla, Shady, Taigen, Tyler, Srounbek, Jakub, Kanj, Mohamed, Santangeli, Pasquale, Saliba, Walid I., Ivorra, Antoni, and Wazni, Oussama M.

Abstract

BACKGROUND: Effects of contact force (CF) on lesion formation during pulsed field ablation (PFA) have not been well validated. The purpose of this study was to determine the relationship between average CF and lesion size during PFA using a swinebeating heart model. METHODS: A 7F catheter with a 3.5-mm ablation electrode and CF sensor (TactiCath SE, Abbott) was connected to a PFA system (CENTAURI, Galvanize Therapeutics). In 5 closed-chest swine, biphasic PFA current was delivered between the ablation electrode and a skin patch at 40 separate sites in right ventricle (28 Amp) and 55 separate sites in left ventricle (35 Amp) with 4 different levels of CF: (1) low (CF range of 4-13 g; median, 9.5 g); (2) moderate (15-30 g; median, 21.5 g); (3) high (34-55 g; median, 40 g); and (4) no electrode contact, 2 mm away from the endocardium. Swine were sacrificed at 2 hours after ablation, and lesion size was measured using triphenyl tetrazolium chloride staining. In 1 additional swine, COX (cytochrome c oxidase) staining was performed to examine mitochondrial activity to delineate reversible and irreversible lesion boundaries. Histological examination was performed with hematoxylin and eosin and Masson trichrome staining. RESULTS: Ablation lesions were well demarcated with triphenyl tetrazolium chloride staining, showing (1) a dark central zone (contraction band necrosis and hemorrhage); (2) a pale zone (no mitochondrial activity and nuclear pyknosis, indicating apoptosis zone); and a hyperstained zone by triphenyl tetrazolium chloride and COX staining (unaffected normal myocardium with preserved mitochondrial activity, consistent with reversible zone). At constant PFA current intensity, lesion depth increased significantly with increasing CF. There were no detectable lesions resulting from ablation without electrode contact. CONCLUSIONS: Acute PFA ventricular lesions show irreversible and reversible lesion boundaries by triphenyl tetrazolium chloride staining. Electrode-tissue contact is required for effective lesion formation during PFA. At the same PFA dose, lesion depth increases significantly with increasing CF. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. PO-01-190 ATRIAL FIBRILLATION ABLATION IN PATIENTS WITH HEART FAILURE

Author

Younis, Arwa, primary, Tabaja, Chadi, additional, Santangeli, Pasquale, additional, Madden, Ruth A., additional, Taigen, Tyler L., additional, Braghieri, Lorenzo, additional, Rickard, John, additional, Klein, Benjamin, additional, Callahan, Thomas D., additional, Martin, David O., additional, Nakhla, Shady, additional, Kanj, Mohamed, additional, Sroubek, Jakub, additional, Nakagawa, Hiroshi, additional, Tchou, Patrick J., additional, Yavin, Hagai, additional, Saliba, Walid I., additional, Wazni, Oussama M., additional, and Hussein, Ayman A., additional

Published
2023
Full Text
View/download PDF

31. PO-01-227 CATHETER ABLATION OUTCOMES OF ATRIAL FIBRILLATION IN ELDERLY AND VERY ELDERLY PATIENTS

Author

Tabaja, Chadi, primary, Younis, Arwa, additional, Santangeli, Pasquale, additional, Madden, Ruth A., additional, Taigen, Tyler L., additional, Braghieri, Lorenzo, additional, Farwati, Medhat, additional, Rickard, John, additional, klein, Benjamin, additional, Dresing, Thomas J., additional, Martin, David O., additional, Bhargava, Mandeep, additional, Kanj, Mohamed, additional, Sroubek, Jakub, additional, Nakagawa, Hiroshi, additional, Tchou, Patrick J., additional, Saliba, Walid I., additional, Wazni, Oussama M., additional, and Hussein, Ayman A., additional

Published
2023
Full Text
View/download PDF

32. PO-01-021 VASCULAR ACCESS COMPLICATIONS DURING CATHETER ABLATION OF VENTRICULAR ARRHYTHMIAS: IMPACT OF VASCULAR CLOSURE DEVICE

Author

Hight, Nolan, primary, Hussein, Ayman A., additional, Sroubek, Jakub, additional, Saliba, Walid I., additional, Kanj, Mohamed, additional, Bhargava, Mandeep, additional, Baranowski, Bryan, additional, Callahan, Thomas D., additional, Chung, Mina K., additional, Dresing, Thomas J., additional, Lee, Justin Z., additional, Martin, David O., additional, Nakhla, Shady, additional, Rickard, John, additional, Taigen, Tyler L., additional, Tchou, Patrick J., additional, Wazni, Oussama M., additional, and Santangeli, Pasquale, additional

Published
2023
Full Text
View/download PDF

33. PO-02-218 IMPACT OF OBESITY ON CATHETER ABLATION OF ATRIAL FIBRILLATION: PATIENT CHARACTERISTICS, PROCEDURAL COMPLICATIONS, OUTCOMES AND QUALITY OF LIFE

Author

Tabaja, Chadi, primary, Younis, Arwa, additional, Santangeli, Pasquale, additional, Madden, Ruth A., additional, Taigen, Tyler L., additional, Farwati, Medhat, additional, Braghieri, Lorenzo, additional, Lee, Justin Z., additional, Baranowski, Bryan, additional, Callahan, Thomas D., additional, Chung, Mina K., additional, Bhargava, Mandeep, additional, Kanj, Mohamed, additional, Sroubek, Jakub, additional, Nakagawa, Hiroshi, additional, Tchou, Patrick J., additional, Saliba, Walid I., additional, Wazni, Oussama M., additional, and Hussein, Ayman A., additional

Published
2023
Full Text
View/download PDF

34. First-in-human Experience with Impella 5.0/5.5 for High-Risk Patients with Advanced Heart Failure Undergoing VT Ablation

Author

Sroubek, Jakub, primary, Vajapey, Ramya, additional, Sipko, Joseph J., additional, Soltesz, Edward G., additional, Weiss, Aaron J., additional, Bhargava, Mandeep, additional, Hussein, Ayman A., additional, Kanj, Mohamed, additional, Saliba, Walid I., additional, Taigen, Tyler L., additional, Wazni, Oussama M., additional, and Santangeli, Pasquale, additional

Published
2023
Full Text
View/download PDF

36. PO-02-221 THE EFFECT OF PRIOR ANTIARRHYTHMIC DRUG USE ON CATHETER ABLATION OF ATRIAL FIBRILLATION: COMPLICATIONS, OUTCOMES AND QUALITY OF LIFE

Author

Younis, Arwa, primary, Tabaja, Chadi, additional, Santangeli, Pasquale, additional, Madden, Ruth A., additional, Taigen, Tyler L., additional, Braghieri, Lorenzo, additional, Rickard, John, additional, Callahan, Thomas D., additional, Martin, David O., additional, Bhargava, Mandeep, additional, Yavin, Hagai, additional, Kanj, Mohamed, additional, Sroubek, Jakub, additional, Nakagawa, Hiroshi, additional, Tchou, Patrick J., additional, Saliba, Walid I., additional, Wazni, Oussama M., additional, and Hussein, Ayman A., additional

Published
2023
Full Text
View/download PDF

37. Impact of Obesity on Catheter Ablation of Atrial fibrillation: Patient Characteristics, Procedural Complications, Outcomes and Quality of Life

Author

Tabaja, Chadi, primary, Younis, Arwa, additional, Santangeli, Pasquale, additional, Farwati, Medhat, additional, Braghieri, Lorenzo, additional, Nakagawa, Hiroshi, additional, Saliba, Walid I, additional, Madden, Ruth, additional, Bouscher, Patricia, additional, Kanj, Mohamed, additional, Callahan, Thomas Daniel, additional, Martin, David O., additional, Bhargava, Mandeep, additional, Chung, Mina K., additional, Baranowski, Bryan, additional, Sroubek, Jakub, additional, Lee, Justin Z, additional, Taigen, Tyler, additional, Nakhla, Shady, additional, Tchou, Patrick, additional, Wazni, Oussama, additional, and Hussein, Ayman, additional

Published
2023
Full Text
View/download PDF

39. Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life.

Author

Tabaja, Chadi, Younis, Arwa, Santageli, Pasquale, Farwati, Medhat, Braghieri, Lorenzo, Nakagawa, Hiroshi, Saliba, Walid I., Madden, Ruth, Bouscher, Patricia, Kanj, Mohamed, Callahan, Thomas D., Martin, David, Bhargava, Mandeep, Chung, Mina, Baranowski, Bryan, Nakhla, Shady, Sroubek, Jakub, Lee, Justin, Taigen, Tyler, and Wazni, Oussama M.

Subjects
OBESITY complications, CONFIDENCE intervals, MULTIVARIATE analysis, ATRIAL fibrillation, CATHETER ablation, SURGICAL complications, HEALTH outcome assessment, DISEASE relapse, TREATMENT effectiveness, RISK assessment, DESCRIPTIVE statistics, BODY mass index, LONGITUDINAL method, PROPORTIONAL hazards models, DISEASE risk factors
Abstract

Introduction: Obesity is a well‐known risk factor for atrial fibrillation (AF). We aim to evaluate the effect of baseline obesity on procedural complications, AF recurrence, and symptoms following catheter ablation (CA). Methods: All consecutive patients undergoing AF ablation (2013–2021) at our center were enrolled in a prospective registry. The study included all consecutive patients with available data on body mass index (BMI). Primary endpoint was AF recurrence based on electrocardiographic documentation. Patients were categorized into five groups according to their baseline BMI. Patients survey at baseline and at follow‐up were used to calculate AF symptom severity score (AFSS) as well as AF burden (mean of AF duration score and AF frequency score; scale 0: no AF to 10: continuous and 9 frequencies/durations in between). Patients were scheduled for follow‐up visits with 12‐lead electrocardiogram at 3, 6, and 12 months after ablation, and every 6 months thereafter. Results: A total of 5841 patients were included (17% normal weight, 34% overweight, 27% Class I, 13% Class II, and 9% Class III obesity). Major procedural complications were low (1.5%) among all BMI subgroups. At 3 years AF recurrence was the highest in Class III obesity patients (48%) followed by Class II (43%), whereas Class I, normal, and overweight had similar results with lower recurrence (35%). In multivariable analyses, Class III obesity (BMI ≥ 40) was independently associated with increased risk for AF recurrence (hazard ratio, 1.30; confidence interval, 1.06–1.60; p =.01), whereas other groups had similar risk in comparison to normal weight. Baseline AFSS was lowest in normal weight, and highest in Obesity‐III, median (interquartile range) 10 (5–16) versus 15 (10–21). In all groups, CA resulted in a significant improvement in their AFSS with a similar magnitude among the groups. At follow‐up, AF burden was minimal and did not differ significantly between the groups. Conclusion: AF ablation is safe with a low complication rate across all BMI groups. Morbid obesity (BMI ≥ 40) was significantly associated with reduced AF ablation success. However, ablation resulted in improvement in QoL including reduction of the AFSS, and AF burden regardless of BMI. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

40. LB-469804-01 A RANDOMIZED CONTROLLED TRIAL OF A LATTICE-TIP MAPPING AND ABLATION SYSTEM WITH RADIOFREQUENCY AND PULSED FIELD ENERGY FOR TREATING PERSISTENT ATRIAL FIBRILLATION

Author

Anter, Elad, Mansour, Moussa, Nair, Devi G., Sharma, Dinesh, Taigen, Tyler L., Neuzil, Petr, Kiehl, Erich L., Kautzner, Josef, Osorio, Jose, Mountantonakis, Stavros, Natale, Andrea, Hummel, John D., Amin, Anish K., Siddiqui, Usman R., Harlev, Doron, Hultz, Paul, Liu, Shufeng, Onal, Birce, Tarakji, Khaldoun G., and Reddy, Vivek Y.

Published
2024
Full Text
View/download PDF

41. Machine Learning Prediction of Pericardial Tamponade After Atrial Fibrillation Ablation

Author

Bansal, Agam, primary, Cantillon, Daniel, additional, Nakhla, Shady, additional, Madden, Ruth, additional, Donnellan, Eoin, additional, Chung, Mina, additional, Rickard, John, additional, Baranowski, Brian, additional, Hussein, Ayman, additional, Saliba, Walid, additional, Kanj, Mohamed, additional, Tarakji, Khaldoun, additional, Wazni, Oussama, additional, and Taigen, Tyler, additional

Published
2022
Full Text
View/download PDF

42. PO-649-07 SAFETY OF SAME-DAY DISCHARGE AFTER PULMONARY VEIN ISOLATION: CONTEMPORARY SINGLE CENTER EXPERIENCE

Author

Aguilera, Jose, primary, Cantillon, Daniel J., additional, Kiang, Alan, additional, Hutt, Erika, additional, Madden, Ruth A., additional, Bouscher, Patricia, additional, Kanj, Mohamed, additional, Saliba, Walid I., additional, Rickard, John, additional, Callahan, Thomas D., additional, Chung, Mina K., additional, Baranowski, Bryan, additional, Dresing, Thomas J., additional, Nakhla, Shady, additional, Wazni, Oussama M., additional, Hussein, Ayman A., additional, and Taigen, Tyler Louis, additional

Published
2022
Full Text
View/download PDF

45. PO-05-154 CAN CHAT GPT 4.0 PREDICT LONG- TERM ARRYTHMIA FREE SURVIVAL AFTER CATHETER ABLATION FOR ATRIAL FIBRILLATION?

Author

El Hajjar, Abdel Hadi, Tabaja, Chadi, Kassab, Joseph, Younis, Arwa, Farwati, Medhat, Hayashi, Katsuhide, Saliba, Walid I., Kanj, Mohamed, Baranowski, Bryan, Bouscher, Patricia, Madden, Ruth A., Nakhla, Shady, Callahan, Thomas D., Nakagawa, Hiroshi, Martin, David O., Bhargava, Mandeep, Chung, Mina K., Sroubek, Jakub, Lee, Justin Z., Taigen, Tyler L., Wazni, Oussama M., and Hussein, Ayman A.

Published
2024
Full Text
View/download PDF

46. PO-05-144 ATRIAL FIBRILLATION BURDEN AND OUTCOMES OF ABLATION BEYOND STANDARD DEFINITIONS OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION

Author

El Hajjar, Abdel Hadi, Tabaja, Chadi, Younis, Arwa, Farwati, Medhat, Hayashi, Katsuhide, Saliba, Walid I., Al Dalakta, Astefanos, Baranowski, Bryan, Bouscher, Patricia, Madden, Ruth A., Nakhla, Shady, Callahan, Thomas D., Nakagawa, Hiroshi, Martin, David O., Bhargava, Mandeep, Chung, Mina K., Sroubek, Jakub, Lee, Justin Z., Kanj, Mohamed, Taigen, Tyler L., Wazni, Oussama M., and Hussein, Ayman A.

Published
2024
Full Text
View/download PDF

47. PO-05-128 FIGURE OF EIGHT SUTURES VERSUS COLLAGEN BASED DEVICE CLOSURE OF FEMORAL VENOUS ACCESS AFTER CATHETER ABLATION OF ATRIAL FIBRILLATION

Author

Chamseddine, Fatimah, Tabaja, Chadi, Abdulhai, Farah, Younis, Arwa, Santangeli, Pasquale, Madden, Ruth A., Bouscher, Patricia, Farwati, Medhat, Taigen, Tyler L., Sipko, Joseph, Motairek, Issam, Wass, Sojin Y., Demian, Joe, Hayashi, Katsuhide, Paul, Aritra, Liuba, Ioan, Rickard, John, Dresing, Thomas J., Martin, David O., Bhargava, Mandeep, Kanj, Mohamed, Sroubek, Jakub, Nakagawa, Hiroshi, Chung, Mina K., Nakhla, Shady, Saliba, Walid I., Wazni, Oussama M., and Hussein, Ayman A.

Published
2024
Full Text
View/download PDF

50. PO-03-158 IMPACT OF BASELINE CHA2DS2-VASC SCORE ON PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE FOLLOWING CATHETER ABLATION OF ATRIAL FIBRILLATION

Author

Farwati, Medhat, Younis, Arwa, Tabaja, Chadi, Demian, Joe, Saliba, Walid I., Bhargava, Mandeep, Santangeli, Pasquale, Lee, Justin Z., Nakhla, Shady, Kanj, Mohamed, Martin, David O., Callahan, Thomas D., Sroubek, Jakub, Taigen, Tyler L., Baranowski, Bryan, Chung, Mina K., Nakagawa, Hiroshi, Wazni, Oussama M., and Hussein, Ayman A.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results